Patents Represented by Attorney McKeon Meunier Carlin & Curfman LLC
  • Patent number: 7995612
    Abstract: Systems and methods for capturing communication signals are provided. An exemplary method comprises the steps of: installing a first type of tapping devices to obtain 32-bit communication signals; installing a recording system that is coupled to the first type of tapping devices; receiving the 32-bit communication signals from the first type of tapping devices via the recording system; responsive to receiving the 32-bit communication signals, converting the 32-bit communication signals into an 128-bit communication format via the recording system; and recording the converted 128-bit communication signals via the recording system.
    Type: Grant
    Filed: March 31, 2006
    Date of Patent: August 9, 2011
    Assignee: Verint Americas, Inc.
    Inventors: Dan Spohrer, Thomas Z. Dong, Marc Calahan
  • Patent number: 7977498
    Abstract: A process for the removal of sterols, specifically cholesterol, from a triglyceride oil, preferably a marine triglyceride oil, said process comprising contacting an oil with an absorbent, specifically TRIS YL™, clay or a mixture thereof, heating the mixture to 100° C. to 210° C., preferably 150° C. to 170° C., preferably for a time period of greater than one minute and optionally at a pressure less than 133 Pa, preferably less than 1.33 Pa.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: July 12, 2011
    Assignee: Ocean Nutrition Canada Limited
    Inventor: Weijie Wang
  • Patent number: 7964187
    Abstract: The present invention relates to a method of increasing the sensitivity of neoplastic cells to chemotherapeutic agents by using a virus, a method of treating proliferative disorders with a virus and chemotherapeutic agents, and a method for preventing a neoplasm from developing drug resistance to chemotherapeutic agents. The virus is preferably a reovirus.
    Type: Grant
    Filed: September 8, 2009
    Date of Patent: June 21, 2011
    Assignee: Oncolytics Biotech Inc.
    Inventors: Matthew C. Coffey, Bradley G. Thompson
  • Patent number: 7888412
    Abstract: The present invention relates to processes utilizing ionic liquids for the dissolution of various polymers and/or copolymers, the formation of resins and blends, and the reconstitution of polymer and/or copolymer solutions, and the dissolution and blending of “functional additives” and/or various polymers and/or copolymers to form advanced composite materials.
    Type: Grant
    Filed: March 24, 2005
    Date of Patent: February 15, 2011
    Assignee: Board of Trustees of the University of Alabama
    Inventors: John D. Holbrey, Richard P. Swatloski, Ji Chen, Dan Daly, Robin D. Rogers
  • Patent number: 7879310
    Abstract: Disclosed are compositions, methods, and devices that generally relate to silanes and silicides and to uses thereof for hydrogen generation. Methods and devices for generating hydrogen for fuel cells and for other applications such as fuel or a supplementary fuel for internal combustion engines and reducing agents to improve catalyst efficiency are also disclosed.
    Type: Grant
    Filed: August 2, 2006
    Date of Patent: February 1, 2011
    Assignee: Board of Trustees of the University of Alabama
    Inventors: Scott K. Spear, Daniel T. Daly, Richard P. Swatloski, Raymond E. Paggi, Michael D. Redemer
  • Patent number: 7846678
    Abstract: Provided herein are methods for detecting gram negative bacteria or lipopolysaccharide in a sample. Kits for detecting gram negative bacteria or lipopolysaccharide in a sample are provided.
    Type: Grant
    Filed: August 18, 2008
    Date of Patent: December 7, 2010
    Assignee: BioDtech, Inc.
    Inventors: Michael G. Pepe, Milton Keith Champion
  • Patent number: 7803385
    Abstract: The invention provides for modified reovirus nucleic acid sequences and modified reovirus polypeptide sequences as well as reoviruses containing such modified nucleic acid or polypeptide sequences. The invention also provides for pharmaceutical compositions that include reoviruses having a modified sequence as well as methods of making and using such reoviruses.
    Type: Grant
    Filed: March 11, 2008
    Date of Patent: September 28, 2010
    Assignee: Oncolytics Biotech Inc.
    Inventor: Matthew C. Coffey
  • Patent number: 7799329
    Abstract: Methods for treating cell proliferative disorders by administering virus to proliferating cells having an activated Ras-pathway are disclosed. The virus is administered so that it ultimately directly contacts proliferating cells having an activated Ras-pathway. Proliferative disorders include but are not limited to neoplasms. The virus is selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus orf virus. Also disclosed are methods for treating cell proliferative disorders by further administering an immunosuppressive agent.
    Type: Grant
    Filed: May 30, 2007
    Date of Patent: September 21, 2010
    Assignee: Oncolytics Biotech Inc.
    Inventors: Matthew C. Coffey, Bradley G. Thompson